Detalhe da pesquisa
1.
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry.
Eur J Nucl Med Mol Imaging
; 51(3): 885-895, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889298
2.
Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer.
Eur J Nucl Med Mol Imaging
; 50(9): 2899-2909, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148297
3.
[89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates.
Eur J Nucl Med Mol Imaging
; 49(13): 4736-4747, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35930033
4.
NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
Blood
; 133(21): 2305-2319, 2019 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30814062
5.
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
Lancet Oncol
; 21(4): 581-592, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171429
6.
Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells.
J Immunol
; 190(11): 5534-44, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23636054
7.
Peroxisome proliferator-activated receptor γ, coactivator 1α deletion induces angiotensin II-associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation.
Arterioscler Thromb Vasc Biol
; 33(8): 1928-35, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23788763
8.
225Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy: Pilot Experience From a Prospective Registry.
Clin Nucl Med
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769643
9.
Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT.
Sci Rep
; 14(1): 11271, 2024 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760451
10.
[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis.
Cancer Imaging
; 24(1): 27, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389092
11.
[161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617.
Theranostics
; 14(5): 1829-1840, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38505615
12.
α1AMP-activated protein kinase mediates vascular protective effects of exercise.
Arterioscler Thromb Vasc Biol
; 32(7): 1632-41, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22539595
13.
New Horizons in Radioligand Therapy: 161Tb-PSMA-617 in Advanced mCRPC.
Clin Nucl Med
; 48(5): 433-434, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758550
14.
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations.
Cancers (Basel)
; 15(9)2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174058
15.
Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker.
Front Med (Lausanne)
; 10: 1339160, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298510
16.
Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.
Blood
; 114(12): 2476-88, 2009 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19584403
17.
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice.
Ther Adv Med Oncol
; 13: 17588359211012361, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33995597
18.
Deficiency of Antioxidative Paraoxonase 2 (Pon2) Leads to Increased Number of Phenotypic LT-HSCs and Disturbed Erythropoiesis.
Oxid Med Cell Longev
; 2021: 3917028, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34257800
19.
Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy.
EJNMMI Phys
; 8(1): 40, 2021 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33950333
20.
Impact of prompt gamma emission of 44Sc on quantification in preclinical and clinical PET systems.
Appl Radiat Isot
; 170: 109599, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33515928